| 1.4 |
1.4 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 1.2 |
4.8 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 1.1 |
5.4 |
GO:0015891 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 1.0 |
1.0 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.9 |
2.6 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.9 |
2.6 |
GO:1901076 |
positive regulation of engulfment of apoptotic cell(GO:1901076) |
| 0.8 |
5.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.8 |
4.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.8 |
2.3 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.7 |
2.2 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 0.7 |
2.2 |
GO:0045360 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.7 |
2.2 |
GO:0060796 |
regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.7 |
0.7 |
GO:1902994 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.7 |
2.1 |
GO:0001798 |
positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.7 |
6.0 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.7 |
5.3 |
GO:0036018 |
cellular response to erythropoietin(GO:0036018) |
| 0.7 |
0.7 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.6 |
4.4 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.6 |
0.6 |
GO:0006667 |
sphinganine metabolic process(GO:0006667) |
| 0.6 |
1.9 |
GO:1904603 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.6 |
1.9 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 0.6 |
1.8 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.6 |
2.4 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 0.6 |
1.8 |
GO:0002731 |
negative regulation of dendritic cell cytokine production(GO:0002731) |
| 0.6 |
2.4 |
GO:0032773 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 0.6 |
2.3 |
GO:0014859 |
negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.6 |
3.5 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.6 |
1.7 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.6 |
1.7 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.6 |
1.7 |
GO:0014876 |
response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.6 |
0.6 |
GO:0032618 |
interleukin-15 production(GO:0032618) |
| 0.6 |
1.7 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 0.5 |
1.6 |
GO:1901207 |
regulation of heart looping(GO:1901207) |
| 0.5 |
2.1 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 0.5 |
0.5 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.5 |
5.2 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.5 |
1.5 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) histone H3-K9 deacetylation(GO:1990619) |
| 0.5 |
3.6 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 0.5 |
2.0 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.5 |
2.0 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 0.5 |
2.5 |
GO:1904844 |
response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.5 |
1.5 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 0.5 |
1.0 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.5 |
1.4 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.5 |
1.4 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.5 |
2.8 |
GO:0030421 |
defecation(GO:0030421) |
| 0.5 |
0.5 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.5 |
2.8 |
GO:0002803 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 0.5 |
0.5 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.5 |
1.4 |
GO:1990910 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) response to hypobaric hypoxia(GO:1990910) |
| 0.4 |
0.4 |
GO:0035150 |
regulation of tube size(GO:0035150) |
| 0.4 |
1.3 |
GO:1990764 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.4 |
0.9 |
GO:0060584 |
regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.4 |
1.3 |
GO:0070446 |
cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
| 0.4 |
0.4 |
GO:0071461 |
cellular response to redox state(GO:0071461) |
| 0.4 |
1.3 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 |
2.1 |
GO:2000110 |
negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.4 |
3.8 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
3.8 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
1.2 |
GO:0021571 |
rhombomere 5 development(GO:0021571) |
| 0.4 |
0.4 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.4 |
2.1 |
GO:0090362 |
positive regulation of platelet-derived growth factor production(GO:0090362) |
| 0.4 |
7.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
2.8 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.4 |
2.0 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.4 |
1.2 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 0.4 |
0.4 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.4 |
2.3 |
GO:0061143 |
alveolar primary septum development(GO:0061143) |
| 0.4 |
1.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.4 |
2.3 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.4 |
0.8 |
GO:2000397 |
regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 0.4 |
0.8 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.4 |
1.5 |
GO:1905224 |
clathrin-coated pit assembly(GO:1905224) |
| 0.4 |
3.0 |
GO:2000860 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.4 |
0.4 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.4 |
1.1 |
GO:0048627 |
myoblast development(GO:0048627) |
| 0.4 |
1.1 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.4 |
0.7 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.4 |
0.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.4 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.4 |
0.4 |
GO:0002519 |
natural killer cell tolerance induction(GO:0002519) |
| 0.4 |
1.1 |
GO:0071629 |
cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
| 0.4 |
1.4 |
GO:0090345 |
cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.4 |
1.8 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.4 |
3.6 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.4 |
1.1 |
GO:0032581 |
ER-dependent peroxisome organization(GO:0032581) |
| 0.4 |
1.8 |
GO:0001315 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.4 |
0.7 |
GO:0048015 |
phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.4 |
1.4 |
GO:0090301 |
regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.3 |
1.0 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.3 |
1.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.3 |
3.0 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
2.0 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.3 |
2.0 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.3 |
1.3 |
GO:1905225 |
response to thyrotropin-releasing hormone(GO:1905225) |
| 0.3 |
1.7 |
GO:0098502 |
DNA dephosphorylation(GO:0098502) |
| 0.3 |
1.7 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.3 |
0.3 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.3 |
1.3 |
GO:0090187 |
positive regulation of pancreatic juice secretion(GO:0090187) |
| 0.3 |
2.0 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.3 |
10.2 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.3 |
3.3 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.3 |
2.0 |
GO:0070221 |
sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.3 |
1.0 |
GO:0061394 |
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.3 |
1.6 |
GO:0042350 |
GDP-L-fucose biosynthetic process(GO:0042350) |
| 0.3 |
1.6 |
GO:1904158 |
axonemal central apparatus assembly(GO:1904158) |
| 0.3 |
1.6 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
0.6 |
GO:1902229 |
regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.3 |
0.3 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.3 |
1.9 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.3 |
0.9 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 0.3 |
1.2 |
GO:0001808 |
negative regulation of type IV hypersensitivity(GO:0001808) |
| 0.3 |
0.9 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.3 |
0.9 |
GO:0002835 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.3 |
1.2 |
GO:1903803 |
glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.3 |
1.5 |
GO:0061737 |
leukotriene signaling pathway(GO:0061737) |
| 0.3 |
1.2 |
GO:0070846 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.3 |
1.8 |
GO:0000820 |
regulation of glutamine family amino acid metabolic process(GO:0000820) |
| 0.3 |
2.7 |
GO:2000660 |
negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
| 0.3 |
1.5 |
GO:0007070 |
negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 0.3 |
0.9 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.3 |
1.2 |
GO:0022007 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.3 |
7.3 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.3 |
0.9 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.3 |
1.5 |
GO:0009440 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 |
0.3 |
GO:2000272 |
negative regulation of receptor activity(GO:2000272) |
| 0.3 |
1.2 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.3 |
0.9 |
GO:0046901 |
tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
| 0.3 |
1.2 |
GO:0050705 |
regulation of interleukin-1 alpha secretion(GO:0050705) |
| 0.3 |
1.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.3 |
1.4 |
GO:2000354 |
regulation of ovarian follicle development(GO:2000354) |
| 0.3 |
4.2 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.3 |
0.3 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.3 |
0.5 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.3 |
1.4 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 |
0.5 |
GO:0019417 |
sulfur oxidation(GO:0019417) |
| 0.3 |
0.5 |
GO:0002428 |
antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.3 |
0.5 |
GO:0046425 |
regulation of JAK-STAT cascade(GO:0046425) regulation of STAT cascade(GO:1904892) |
| 0.3 |
0.8 |
GO:1902565 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.3 |
1.9 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.3 |
0.8 |
GO:0034148 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.3 |
2.4 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.3 |
0.8 |
GO:0002352 |
B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.3 |
0.5 |
GO:1901656 |
glycoside transport(GO:1901656) |
| 0.3 |
1.1 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.3 |
1.0 |
GO:0006550 |
isoleucine catabolic process(GO:0006550) |
| 0.3 |
0.5 |
GO:0038066 |
p38MAPK cascade(GO:0038066) |
| 0.3 |
2.1 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.3 |
3.4 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.3 |
0.5 |
GO:2000400 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.3 |
1.8 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.3 |
2.0 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.3 |
1.5 |
GO:2000538 |
regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 0.3 |
0.8 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.3 |
1.0 |
GO:1990523 |
bone regeneration(GO:1990523) |
| 0.3 |
0.8 |
GO:1903094 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.3 |
0.8 |
GO:0003308 |
negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.2 |
5.2 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.2 |
0.7 |
GO:2000612 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 0.2 |
1.7 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
0.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 |
0.7 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
0.7 |
GO:1903926 |
signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
| 0.2 |
0.2 |
GO:0035026 |
leading edge cell differentiation(GO:0035026) |
| 0.2 |
0.5 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 0.2 |
2.4 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.2 |
0.2 |
GO:0051660 |
establishment of centrosome localization(GO:0051660) |
| 0.2 |
1.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
0.2 |
GO:0021538 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.2 |
0.2 |
GO:0009566 |
fertilization(GO:0009566) |
| 0.2 |
2.1 |
GO:0009972 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.2 |
2.4 |
GO:0033087 |
negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.2 |
GO:0048593 |
camera-type eye morphogenesis(GO:0048593) |
| 0.2 |
1.2 |
GO:0090182 |
regulation of secretion of lysosomal enzymes(GO:0090182) |
| 0.2 |
0.5 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
0.7 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 0.2 |
1.1 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 |
0.5 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.2 |
0.2 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.2 |
1.1 |
GO:0060214 |
endocardium formation(GO:0060214) |
| 0.2 |
0.7 |
GO:0009078 |
alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
| 0.2 |
1.8 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 |
0.7 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 0.2 |
0.4 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.2 |
1.8 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 |
0.7 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.2 |
0.7 |
GO:0010160 |
sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
| 0.2 |
1.1 |
GO:0015817 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.2 |
1.1 |
GO:0070980 |
biphenyl catabolic process(GO:0070980) |
| 0.2 |
0.7 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 |
0.7 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 |
0.9 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.2 |
0.2 |
GO:0051025 |
negative regulation of immunoglobulin secretion(GO:0051025) |
| 0.2 |
0.4 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.2 |
2.2 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
0.7 |
GO:0035803 |
egg coat formation(GO:0035803) |
| 0.2 |
0.6 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 0.2 |
0.6 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.2 |
0.9 |
GO:1903949 |
positive regulation of atrial cardiac muscle cell action potential(GO:1903949) |
| 0.2 |
1.1 |
GO:0030807 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.2 |
0.2 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 |
0.2 |
GO:0002583 |
regulation of antigen processing and presentation of peptide antigen(GO:0002583) |
| 0.2 |
0.6 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.2 |
2.8 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.2 |
0.2 |
GO:0090107 |
regulation of high-density lipoprotein particle assembly(GO:0090107) |
| 0.2 |
0.9 |
GO:0098968 |
neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.2 |
0.6 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.2 |
0.2 |
GO:0046959 |
nonassociative learning(GO:0046958) habituation(GO:0046959) |
| 0.2 |
0.4 |
GO:0019216 |
regulation of lipid metabolic process(GO:0019216) |
| 0.2 |
1.9 |
GO:0034127 |
regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034127) |
| 0.2 |
0.4 |
GO:0060149 |
negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by miRNA(GO:0060965) negative regulation of gene silencing by RNA(GO:0060967) |
| 0.2 |
0.6 |
GO:0015881 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 0.2 |
0.4 |
GO:0010621 |
negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.2 |
0.6 |
GO:1990709 |
presynaptic active zone organization(GO:1990709) |
| 0.2 |
14.7 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
0.6 |
GO:0060720 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 |
0.6 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.2 |
0.2 |
GO:0071874 |
response to norepinephrine(GO:0071873) cellular response to norepinephrine stimulus(GO:0071874) |
| 0.2 |
0.4 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.2 |
0.8 |
GO:0090212 |
detection of temperature stimulus involved in thermoception(GO:0050960) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
| 0.2 |
0.2 |
GO:0090214 |
spongiotrophoblast layer developmental growth(GO:0090214) |
| 0.2 |
2.0 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
1.0 |
GO:0034442 |
regulation of lipoprotein oxidation(GO:0034442) |
| 0.2 |
0.8 |
GO:0070893 |
transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
| 0.2 |
1.4 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.2 |
0.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 0.2 |
0.4 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.2 |
0.6 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.2 |
2.4 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 |
1.8 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
0.8 |
GO:1903721 |
regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.2 |
2.6 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
1.0 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 |
0.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) |
| 0.2 |
0.8 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
0.6 |
GO:0035674 |
tricarboxylic acid transmembrane transport(GO:0035674) |
| 0.2 |
1.8 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
1.2 |
GO:0045903 |
positive regulation of translational fidelity(GO:0045903) |
| 0.2 |
0.8 |
GO:0015819 |
lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 0.2 |
1.2 |
GO:0003404 |
optic vesicle morphogenesis(GO:0003404) |
| 0.2 |
0.8 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.2 |
2.1 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.2 |
0.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.2 |
0.4 |
GO:0090034 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.2 |
1.0 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.2 |
0.6 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 0.2 |
0.2 |
GO:0006801 |
superoxide metabolic process(GO:0006801) |
| 0.2 |
1.5 |
GO:0052697 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.2 |
0.6 |
GO:0050823 |
peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
| 0.2 |
1.5 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 0.2 |
0.8 |
GO:0002501 |
peptide antigen assembly with MHC protein complex(GO:0002501) peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 |
3.4 |
GO:1901748 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.2 |
0.2 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 0.2 |
0.4 |
GO:1990668 |
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane(GO:1990668) |
| 0.2 |
0.4 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.2 |
0.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
0.4 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.2 |
0.2 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.2 |
0.9 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
0.4 |
GO:0052251 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.2 |
0.2 |
GO:1900046 |
regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.2 |
0.6 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.2 |
2.0 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 |
0.4 |
GO:0002581 |
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.2 |
1.8 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.2 |
2.0 |
GO:0098795 |
mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.2 |
1.7 |
GO:0061370 |
testosterone biosynthetic process(GO:0061370) |
| 0.2 |
5.9 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.2 |
0.7 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.2 |
0.6 |
GO:0014707 |
branchiomeric skeletal muscle development(GO:0014707) |
| 0.2 |
4.4 |
GO:0043401 |
steroid hormone mediated signaling pathway(GO:0043401) |
| 0.2 |
1.8 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.2 |
0.9 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.2 |
0.4 |
GO:0033081 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.2 |
0.5 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.2 |
0.5 |
GO:0071672 |
negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.2 |
0.9 |
GO:2000399 |
negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
| 0.2 |
2.3 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.4 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.2 |
0.5 |
GO:1904899 |
regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 0.2 |
0.5 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.2 |
2.6 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.5 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.2 |
0.2 |
GO:0070365 |
hepatocyte differentiation(GO:0070365) |
| 0.2 |
0.5 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.2 |
0.7 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.2 |
0.5 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.2 |
0.3 |
GO:1902563 |
regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
| 0.2 |
1.0 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.2 |
0.9 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.2 |
0.5 |
GO:0002580 |
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) |
| 0.2 |
3.6 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 |
0.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.2 |
1.4 |
GO:0060154 |
cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 0.2 |
2.2 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 |
1.2 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.2 |
0.3 |
GO:0002029 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) adaptation of signaling pathway(GO:0023058) |
| 0.2 |
0.5 |
GO:1901873 |
regulation of post-translational protein modification(GO:1901873) |
| 0.2 |
0.2 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 0.2 |
0.2 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.2 |
0.5 |
GO:0046463 |
neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.2 |
0.7 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.2 |
1.8 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) |
| 0.2 |
1.5 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.2 |
0.3 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.2 |
0.5 |
GO:0044691 |
tooth eruption(GO:0044691) |
| 0.2 |
0.2 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.2 |
0.5 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 |
0.5 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 |
0.3 |
GO:0043376 |
regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.2 |
2.6 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
1.3 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.2 |
0.3 |
GO:0031214 |
biomineral tissue development(GO:0031214) |
| 0.2 |
0.5 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 0.2 |
0.5 |
GO:0046521 |
sphingoid catabolic process(GO:0046521) |
| 0.2 |
0.3 |
GO:0046968 |
peptide antigen transport(GO:0046968) |
| 0.2 |
0.3 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.2 |
2.1 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 |
0.2 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.2 |
1.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.2 |
0.3 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.2 |
0.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.3 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.2 |
0.5 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.2 |
0.5 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.2 |
3.0 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
0.8 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.2 |
1.1 |
GO:0097168 |
mesenchymal stem cell proliferation(GO:0097168) |
| 0.2 |
1.1 |
GO:0071847 |
TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.2 |
2.2 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 |
1.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.5 |
GO:0006427 |
histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 |
2.3 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.2 |
0.8 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.2 |
0.3 |
GO:0035065 |
regulation of histone acetylation(GO:0035065) regulation of peptidyl-lysine acetylation(GO:2000756) |
| 0.2 |
0.5 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.2 |
0.3 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.2 |
0.6 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.2 |
0.3 |
GO:0070676 |
intralumenal vesicle formation(GO:0070676) |
| 0.2 |
0.3 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.2 |
2.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.2 |
0.5 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.2 |
0.5 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
1.5 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
0.8 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.7 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
0.4 |
GO:0006258 |
UDP-glucose catabolic process(GO:0006258) |
| 0.1 |
0.3 |
GO:0045079 |
negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 |
5.5 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.1 |
1.3 |
GO:0006701 |
progesterone biosynthetic process(GO:0006701) |
| 0.1 |
0.4 |
GO:0048210 |
Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.1 |
1.8 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.1 |
1.3 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
0.4 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.1 |
0.7 |
GO:0030037 |
actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.1 |
0.6 |
GO:0003335 |
corneocyte development(GO:0003335) |
| 0.1 |
1.0 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
23.1 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.7 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.1 |
0.9 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.1 |
0.4 |
GO:0031296 |
B cell costimulation(GO:0031296) |
| 0.1 |
0.7 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
0.1 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.1 |
0.1 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.1 |
0.9 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 |
1.0 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
1.6 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
1.6 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.1 |
0.1 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
1.1 |
GO:0039663 |
fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 |
0.7 |
GO:0030573 |
bile acid catabolic process(GO:0030573) |
| 0.1 |
0.4 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.1 |
GO:1904640 |
response to methionine(GO:1904640) |
| 0.1 |
1.0 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
2.5 |
GO:0034356 |
NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 |
0.3 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
1.1 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.8 |
GO:0051673 |
membrane disruption in other organism(GO:0051673) |
| 0.1 |
2.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.1 |
0.5 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.7 |
GO:0032479 |
regulation of type I interferon production(GO:0032479) |
| 0.1 |
0.4 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
| 0.1 |
0.3 |
GO:0071158 |
positive regulation of cell cycle arrest(GO:0071158) |
| 0.1 |
0.8 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.3 |
GO:0097065 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.1 |
0.7 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
0.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.1 |
7.7 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.1 |
0.3 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 0.1 |
4.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
0.7 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
1.9 |
GO:0046051 |
UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.1 |
0.7 |
GO:0023035 |
CD40 signaling pathway(GO:0023035) |
| 0.1 |
0.5 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.1 |
0.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.1 |
0.9 |
GO:0000432 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.1 |
0.4 |
GO:0006680 |
glucosylceramide catabolic process(GO:0006680) |
| 0.1 |
0.7 |
GO:0038155 |
interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.1 |
0.8 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.1 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 0.1 |
0.1 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.1 |
0.4 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.1 |
0.1 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.1 |
0.9 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
0.7 |
GO:0036511 |
trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.1 |
0.4 |
GO:0000711 |
meiotic DNA repair synthesis(GO:0000711) |
| 0.1 |
0.5 |
GO:0006482 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 |
1.0 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.1 |
0.4 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 0.1 |
0.5 |
GO:0032229 |
negative regulation of synaptic transmission, GABAergic(GO:0032229) |
| 0.1 |
2.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.1 |
0.1 |
GO:0051683 |
establishment of Golgi localization(GO:0051683) |
| 0.1 |
0.1 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.1 |
0.4 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.8 |
GO:0018032 |
protein amidation(GO:0018032) |
| 0.1 |
0.3 |
GO:0003192 |
mitral valve formation(GO:0003192) |
| 0.1 |
1.1 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.1 |
0.5 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.1 |
0.5 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.1 |
0.8 |
GO:0048241 |
epinephrine transport(GO:0048241) |
| 0.1 |
3.0 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.3 |
GO:0002268 |
follicular dendritic cell differentiation(GO:0002268) |
| 0.1 |
1.0 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.1 |
1.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.4 |
GO:0033037 |
polysaccharide localization(GO:0033037) |
| 0.1 |
0.3 |
GO:0032691 |
negative regulation of interleukin-1 beta production(GO:0032691) |
| 0.1 |
1.5 |
GO:0003096 |
renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.1 |
0.9 |
GO:1900113 |
negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 0.1 |
0.3 |
GO:0060748 |
tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
| 0.1 |
0.4 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.1 |
0.4 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.4 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.2 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 |
0.2 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.1 |
0.7 |
GO:0019747 |
regulation of isoprenoid metabolic process(GO:0019747) |
| 0.1 |
0.5 |
GO:0072312 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 |
0.1 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.1 |
0.2 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 |
0.2 |
GO:0060454 |
positive regulation of gastric acid secretion(GO:0060454) |
| 0.1 |
0.7 |
GO:0050755 |
chemokine metabolic process(GO:0050755) |
| 0.1 |
0.4 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.5 |
GO:1905244 |
regulation of modification of synaptic structure(GO:1905244) |
| 0.1 |
1.3 |
GO:0042905 |
9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
| 0.1 |
0.4 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
1.8 |
GO:0005984 |
disaccharide metabolic process(GO:0005984) |
| 0.1 |
0.4 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.5 |
GO:1902499 |
positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 |
3.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.1 |
0.7 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.1 |
0.8 |
GO:0090154 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.5 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.2 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.1 |
0.2 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 0.1 |
0.1 |
GO:0007635 |
chemosensory behavior(GO:0007635) olfactory behavior(GO:0042048) |
| 0.1 |
0.8 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.1 |
0.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.1 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.2 |
GO:0009609 |
response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
| 0.1 |
0.6 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.1 |
1.5 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) |
| 0.1 |
0.3 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
1.2 |
GO:0019375 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.1 |
0.3 |
GO:0048250 |
mitochondrial iron ion transport(GO:0048250) |
| 0.1 |
0.6 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.1 |
0.5 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.1 |
1.3 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.1 |
0.1 |
GO:0018879 |
biphenyl metabolic process(GO:0018879) |
| 0.1 |
0.2 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 |
0.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
1.5 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.1 |
0.5 |
GO:0019056 |
modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.1 |
0.8 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 |
0.2 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
| 0.1 |
5.1 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.7 |
GO:0021539 |
subthalamus development(GO:0021539) |
| 0.1 |
0.1 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.1 |
0.2 |
GO:0006772 |
thiamine metabolic process(GO:0006772) |
| 0.1 |
0.4 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.1 |
1.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.2 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.1 |
3.8 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
1.8 |
GO:2000404 |
regulation of T cell migration(GO:2000404) |
| 0.1 |
0.6 |
GO:0071934 |
thiamine transmembrane transport(GO:0071934) |
| 0.1 |
0.9 |
GO:0071888 |
macrophage apoptotic process(GO:0071888) |
| 0.1 |
0.6 |
GO:0032364 |
oxygen homeostasis(GO:0032364) |
| 0.1 |
1.0 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.9 |
GO:0046149 |
porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 |
0.6 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.1 |
GO:0002704 |
negative regulation of leukocyte mediated immunity(GO:0002704) |
| 0.1 |
1.0 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.1 |
0.4 |
GO:1900425 |
negative regulation of defense response to bacterium(GO:1900425) |
| 0.1 |
0.7 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.1 |
0.3 |
GO:1900222 |
negative regulation of beta-amyloid clearance(GO:1900222) |
| 0.1 |
1.0 |
GO:0097116 |
gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 0.1 |
0.1 |
GO:2001239 |
regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
| 0.1 |
0.3 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.3 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.3 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.1 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.1 |
2.4 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 |
0.4 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
1.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.5 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 |
0.9 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 0.1 |
0.3 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
0.1 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
1.2 |
GO:0060767 |
epithelial cell proliferation involved in prostate gland development(GO:0060767) |
| 0.1 |
0.6 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:2001303 |
lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.1 |
7.6 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.3 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.1 |
GO:0061158 |
3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.1 |
0.7 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.1 |
0.7 |
GO:0061622 |
glycolytic process through glucose-1-phosphate(GO:0061622) |
| 0.1 |
0.3 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.1 |
0.3 |
GO:1904798 |
positive regulation of core promoter binding(GO:1904798) |
| 0.1 |
0.2 |
GO:0007402 |
ganglion mother cell fate determination(GO:0007402) |
| 0.1 |
0.3 |
GO:0010983 |
positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
| 0.1 |
0.7 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 |
0.2 |
GO:0048485 |
sympathetic nervous system development(GO:0048485) |
| 0.1 |
0.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
| 0.1 |
2.1 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.1 |
0.4 |
GO:0090410 |
malonate catabolic process(GO:0090410) |
| 0.1 |
0.1 |
GO:0050905 |
neuromuscular process(GO:0050905) |
| 0.1 |
0.3 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.1 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.1 |
0.8 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.5 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.7 |
GO:1904925 |
positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
| 0.1 |
0.6 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.3 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.1 |
0.1 |
GO:0035376 |
sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 |
0.4 |
GO:0010040 |
response to iron(II) ion(GO:0010040) |
| 0.1 |
0.5 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.1 |
0.3 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 |
0.6 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.1 |
0.9 |
GO:0044821 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.1 |
0.4 |
GO:0010979 |
regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
| 0.1 |
1.8 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.1 |
0.5 |
GO:0090156 |
cellular sphingolipid homeostasis(GO:0090156) |
| 0.1 |
0.4 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
0.2 |
GO:0060031 |
mediolateral intercalation(GO:0060031) planar cell polarity pathway involved in gastrula mediolateral intercalation(GO:0060775) |
| 0.1 |
0.3 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 0.1 |
0.1 |
GO:0050906 |
detection of stimulus involved in sensory perception(GO:0050906) |
| 0.1 |
1.0 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
2.4 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 |
0.5 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.1 |
1.1 |
GO:0019934 |
cGMP-mediated signaling(GO:0019934) |
| 0.1 |
0.1 |
GO:0046471 |
phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 |
0.4 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 0.1 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
1.6 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.1 |
0.6 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 |
0.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
0.6 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
2.7 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.1 |
0.1 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.3 |
GO:1903659 |
regulation of complement-dependent cytotoxicity(GO:1903659) |
| 0.1 |
0.6 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.4 |
GO:0050928 |
negative regulation of positive chemotaxis(GO:0050928) |
| 0.1 |
0.3 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
1.1 |
GO:0017182 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.2 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 |
1.1 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.1 |
2.4 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
0.3 |
GO:1904046 |
negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.1 |
0.1 |
GO:0090259 |
regulation of retinal ganglion cell axon guidance(GO:0090259) dorsal root ganglion development(GO:1990791) |
| 0.1 |
2.3 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.1 |
0.4 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
0.2 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.8 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 |
0.3 |
GO:0030505 |
inorganic diphosphate transport(GO:0030505) |
| 0.1 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
0.5 |
GO:1903644 |
regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 |
1.2 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.2 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.1 |
0.4 |
GO:0046909 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
1.1 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.1 |
0.3 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.1 |
0.9 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
0.1 |
GO:0014049 |
positive regulation of glutamate secretion(GO:0014049) |
| 0.1 |
1.1 |
GO:0015760 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.1 |
GO:0048754 |
branching morphogenesis of an epithelial tube(GO:0048754) |
| 0.1 |
1.1 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
8.7 |
GO:0060337 |
type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 |
0.9 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.1 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.1 |
0.2 |
GO:0098989 |
NMDA selective glutamate receptor signaling pathway(GO:0098989) |
| 0.1 |
0.8 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.1 |
0.7 |
GO:0097039 |
protein linear polyubiquitination(GO:0097039) |
| 0.1 |
0.1 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
0.2 |
GO:0009063 |
cellular amino acid catabolic process(GO:0009063) |
| 0.1 |
0.6 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.4 |
GO:0042631 |
cellular response to water deprivation(GO:0042631) |
| 0.1 |
1.0 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.1 |
0.5 |
GO:0033274 |
response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 |
0.3 |
GO:0090260 |
negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
| 0.1 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.1 |
1.1 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.1 |
2.1 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.1 |
0.8 |
GO:0097398 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 |
0.5 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.3 |
GO:2000535 |
regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
1.3 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.4 |
GO:0090076 |
relaxation of skeletal muscle(GO:0090076) |
| 0.1 |
2.2 |
GO:0019731 |
antibacterial humoral response(GO:0019731) |
| 0.1 |
0.3 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.2 |
GO:0035787 |
cell migration involved in kidney development(GO:0035787) negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.1 |
1.3 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.9 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.2 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 |
0.6 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.1 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.1 |
0.3 |
GO:0042091 |
interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
| 0.1 |
0.6 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.1 |
0.4 |
GO:0030241 |
skeletal muscle myosin thick filament assembly(GO:0030241) |
| 0.1 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 |
0.1 |
GO:0060374 |
mast cell differentiation(GO:0060374) |
| 0.1 |
1.0 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
0.4 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.1 |
0.2 |
GO:0045720 |
negative regulation of integrin biosynthetic process(GO:0045720) |
| 0.1 |
0.2 |
GO:0048806 |
genitalia development(GO:0048806) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.2 |
GO:0071104 |
response to interleukin-9(GO:0071104) |
| 0.1 |
0.3 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.5 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 0.1 |
0.1 |
GO:0014901 |
regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.1 |
0.2 |
GO:0006021 |
inositol biosynthetic process(GO:0006021) |
| 0.1 |
0.9 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.6 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.1 |
0.5 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.5 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.1 |
3.2 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.1 |
0.3 |
GO:0045448 |
regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.1 |
0.2 |
GO:0021569 |
rhombomere 3 development(GO:0021569) |
| 0.1 |
1.1 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.1 |
2.0 |
GO:0006554 |
lysine catabolic process(GO:0006554) |
| 0.1 |
0.9 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.1 |
0.3 |
GO:0051001 |
negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 |
0.1 |
GO:0061184 |
positive regulation of dermatome development(GO:0061184) |
| 0.1 |
0.4 |
GO:0007598 |
blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 |
0.5 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.1 |
1.4 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.1 |
0.3 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
2.6 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0070425 |
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 0.1 |
1.3 |
GO:0046951 |
ketone body biosynthetic process(GO:0046951) |
| 0.1 |
0.2 |
GO:0034599 |
cellular response to oxidative stress(GO:0034599) |
| 0.1 |
0.3 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.3 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.1 |
0.9 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.1 |
0.1 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.1 |
0.3 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 |
0.2 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.1 |
0.2 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
0.2 |
GO:0051970 |
negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.1 |
0.3 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.1 |
0.2 |
GO:0021551 |
central nervous system morphogenesis(GO:0021551) cardiac muscle tissue regeneration(GO:0061026) |
| 0.1 |
0.1 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 0.1 |
2.9 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.1 |
0.1 |
GO:0045590 |
negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.1 |
0.2 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.1 |
0.5 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 |
0.3 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.6 |
GO:0021559 |
trigeminal nerve development(GO:0021559) |
| 0.1 |
0.9 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
0.7 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.5 |
GO:1904526 |
regulation of microtubule binding(GO:1904526) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.2 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.6 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
0.1 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.1 |
0.2 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.1 |
0.3 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.1 |
0.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 0.1 |
0.2 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.3 |
GO:1900109 |
regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.1 |
0.2 |
GO:0042144 |
vacuole fusion, non-autophagic(GO:0042144) |
| 0.1 |
0.3 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.1 |
1.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.1 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.7 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.1 |
1.0 |
GO:0003416 |
endochondral bone growth(GO:0003416) |
| 0.1 |
0.6 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.1 |
0.5 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.2 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 0.1 |
0.8 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.1 |
0.9 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.1 |
0.8 |
GO:0002675 |
positive regulation of acute inflammatory response(GO:0002675) |
| 0.1 |
0.2 |
GO:2001015 |
negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 |
4.7 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.5 |
GO:0051181 |
cofactor transport(GO:0051181) |
| 0.1 |
0.4 |
GO:0006050 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.1 |
0.1 |
GO:0033861 |
negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 0.1 |
0.3 |
GO:0071499 |
cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 |
0.5 |
GO:0070235 |
regulation of activation-induced cell death of T cells(GO:0070235) |
| 0.1 |
0.4 |
GO:0048845 |
venous blood vessel morphogenesis(GO:0048845) |
| 0.1 |
0.2 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.1 |
0.2 |
GO:0009443 |
pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.1 |
0.4 |
GO:0018057 |
peptidyl-lysine oxidation(GO:0018057) |
| 0.1 |
0.2 |
GO:0044805 |
late nucleophagy(GO:0044805) |
| 0.1 |
0.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
2.4 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.1 |
0.6 |
GO:0001957 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
0.5 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.4 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.1 |
1.0 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.1 |
0.4 |
GO:0001692 |
histamine metabolic process(GO:0001692) |
| 0.1 |
0.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.2 |
GO:1902527 |
regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.2 |
GO:0052314 |
phytoalexin metabolic process(GO:0052314) |
| 0.1 |
0.8 |
GO:0010968 |
regulation of microtubule nucleation(GO:0010968) |
| 0.1 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.6 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.1 |
0.4 |
GO:0031063 |
regulation of histone deacetylation(GO:0031063) |
| 0.1 |
0.1 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.1 |
0.6 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
| 0.1 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.1 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
0.3 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.1 |
0.1 |
GO:0014839 |
myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.1 |
0.3 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
| 0.1 |
0.7 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.1 |
0.5 |
GO:0097647 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 |
0.3 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.1 |
0.1 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
0.1 |
GO:0043931 |
ossification involved in bone maturation(GO:0043931) |
| 0.1 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
1.4 |
GO:0060044 |
negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.1 |
0.2 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.1 |
0.1 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
0.4 |
GO:0036159 |
inner dynein arm assembly(GO:0036159) |
| 0.1 |
0.3 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.2 |
GO:0035623 |
renal glucose absorption(GO:0035623) |
| 0.1 |
0.6 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.2 |
GO:0044209 |
AMP salvage(GO:0044209) |
| 0.1 |
0.3 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.1 |
GO:0006525 |
arginine metabolic process(GO:0006525) |
| 0.1 |
1.8 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.1 |
0.3 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.1 |
0.1 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.1 |
0.1 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.8 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0061056 |
sclerotome development(GO:0061056) |
| 0.1 |
0.2 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.6 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.1 |
0.4 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.1 |
0.6 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.1 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.1 |
0.3 |
GO:0036343 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.1 |
1.7 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.3 |
GO:0060005 |
vestibular reflex(GO:0060005) |
| 0.1 |
0.9 |
GO:0090179 |
planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.1 |
1.1 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
0.3 |
GO:1902571 |
regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 |
0.2 |
GO:0018874 |
benzoate metabolic process(GO:0018874) |
| 0.1 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.1 |
0.3 |
GO:1904448 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.1 |
0.5 |
GO:0045959 |
regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.1 |
0.2 |
GO:0060263 |
regulation of respiratory burst(GO:0060263) |
| 0.1 |
0.1 |
GO:2001267 |
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.3 |
GO:0043321 |
regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.1 |
0.1 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.1 |
0.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.2 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.1 |
0.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.5 |
GO:0071316 |
cellular response to nicotine(GO:0071316) |
| 0.1 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.7 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.1 |
0.1 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
0.1 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.3 |
GO:0071348 |
cellular response to interleukin-11(GO:0071348) |
| 0.1 |
0.2 |
GO:0060381 |
regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.1 |
0.2 |
GO:0032874 |
positive regulation of stress-activated MAPK cascade(GO:0032874) |
| 0.1 |
0.1 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.2 |
GO:0010807 |
regulation of synaptic vesicle priming(GO:0010807) |
| 0.1 |
0.2 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
0.1 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.1 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 0.1 |
0.2 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.1 |
GO:0002664 |
regulation of T cell tolerance induction(GO:0002664) |
| 0.1 |
0.2 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.1 |
0.1 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 |
0.5 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.1 |
0.1 |
GO:0070585 |
protein localization to mitochondrion(GO:0070585) |
| 0.1 |
0.3 |
GO:0045879 |
negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.1 |
0.1 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.1 |
0.2 |
GO:0032459 |
regulation of protein oligomerization(GO:0032459) |
| 0.1 |
0.7 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.1 |
0.1 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.1 |
GO:0021524 |
visceral motor neuron differentiation(GO:0021524) |
| 0.1 |
0.1 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.3 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.1 |
0.4 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.1 |
0.1 |
GO:1904862 |
inhibitory synapse assembly(GO:1904862) |
| 0.1 |
0.9 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.1 |
1.3 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.1 |
0.4 |
GO:0046985 |
positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.1 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.1 |
0.2 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 |
0.2 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
1.3 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.1 |
0.2 |
GO:0030100 |
regulation of endocytosis(GO:0030100) |
| 0.1 |
0.1 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.1 |
0.1 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.1 |
0.2 |
GO:0002933 |
lipid hydroxylation(GO:0002933) |
| 0.1 |
1.6 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
1.0 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.1 |
GO:1902616 |
acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
| 0.1 |
0.2 |
GO:0019046 |
release from viral latency(GO:0019046) |
| 0.1 |
1.3 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.1 |
GO:0006145 |
purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
| 0.1 |
0.3 |
GO:0036148 |
phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
| 0.1 |
3.2 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.1 |
0.2 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.1 |
0.3 |
GO:0044571 |
[2Fe-2S] cluster assembly(GO:0044571) |
| 0.1 |
0.2 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.4 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.2 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 0.1 |
0.1 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 |
0.3 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.2 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.1 |
1.1 |
GO:0015669 |
gas transport(GO:0015669) oxygen transport(GO:0015671) |
| 0.1 |
0.2 |
GO:0019933 |
cAMP-mediated signaling(GO:0019933) |
| 0.1 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.1 |
0.3 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 0.1 |
0.1 |
GO:0071351 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.9 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
1.1 |
GO:0043567 |
regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.1 |
0.6 |
GO:0040031 |
snRNA modification(GO:0040031) |
| 0.1 |
0.2 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.1 |
0.3 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 |
0.7 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.1 |
0.2 |
GO:1990697 |
protein depalmitoleylation(GO:1990697) |
| 0.1 |
0.2 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.1 |
GO:0019249 |
lactate biosynthetic process(GO:0019249) |
| 0.1 |
1.0 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.1 |
0.2 |
GO:0021718 |
pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.1 |
0.2 |
GO:0048663 |
neuron fate commitment(GO:0048663) |
| 0.1 |
0.1 |
GO:0002396 |
MHC protein complex assembly(GO:0002396) MHC class II protein complex assembly(GO:0002399) |
| 0.1 |
0.3 |
GO:0045065 |
cytotoxic T cell differentiation(GO:0045065) |
| 0.1 |
0.1 |
GO:2001257 |
regulation of cation channel activity(GO:2001257) |
| 0.1 |
0.6 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.8 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
0.5 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.1 |
0.3 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.1 |
3.2 |
GO:1901998 |
toxin transport(GO:1901998) |
| 0.1 |
0.1 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.1 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 |
0.2 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
0.4 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 |
0.3 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
0.2 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.1 |
0.4 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.4 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.1 |
0.1 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.1 |
0.6 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.1 |
0.3 |
GO:0016114 |
terpenoid biosynthetic process(GO:0016114) |
| 0.1 |
0.4 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.1 |
0.4 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
0.1 |
GO:0002027 |
regulation of heart rate(GO:0002027) |
| 0.1 |
0.2 |
GO:0021520 |
spinal cord motor neuron cell fate specification(GO:0021520) |
| 0.1 |
0.8 |
GO:0098828 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
6.1 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
0.2 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
0.4 |
GO:0003266 |
regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.1 |
0.3 |
GO:0045765 |
regulation of angiogenesis(GO:0045765) |
| 0.1 |
0.1 |
GO:0099640 |
axo-dendritic protein transport(GO:0099640) |
| 0.1 |
0.1 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.3 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.1 |
0.2 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
1.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 |
0.3 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.1 |
0.3 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.1 |
0.5 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.1 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.1 |
0.6 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.6 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.1 |
0.3 |
GO:0050974 |
detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 |
0.1 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.1 |
0.2 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.2 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.1 |
0.2 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) cellular response to L-glutamate(GO:1905232) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 |
0.7 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.1 |
0.2 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.1 |
0.5 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.2 |
GO:0060620 |
regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
| 0.0 |
0.2 |
GO:0071313 |
cellular response to caffeine(GO:0071313) |
| 0.0 |
0.0 |
GO:1903170 |
negative regulation of calcium ion transmembrane transport(GO:1903170) |
| 0.0 |
0.3 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) |
| 0.0 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.0 |
0.2 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
| 0.0 |
0.3 |
GO:0007044 |
cell-substrate junction assembly(GO:0007044) |
| 0.0 |
0.6 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.0 |
0.0 |
GO:0070374 |
positive regulation of ERK1 and ERK2 cascade(GO:0070374) |
| 0.0 |
0.1 |
GO:0021983 |
pituitary gland development(GO:0021983) |
| 0.0 |
0.4 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.3 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.1 |
GO:0034343 |
type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.0 |
0.1 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.2 |
GO:0060686 |
regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.0 |
0.5 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.8 |
GO:0042036 |
negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.0 |
0.4 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.0 |
0.4 |
GO:0051195 |
negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.3 |
GO:0002729 |
positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 0.0 |
0.3 |
GO:0060281 |
regulation of oocyte development(GO:0060281) |
| 0.0 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.2 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.0 |
0.5 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.1 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.0 |
0.0 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.2 |
GO:0046219 |
indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
| 0.0 |
0.1 |
GO:1902093 |
positive regulation of sperm motility(GO:1902093) |
| 0.0 |
0.2 |
GO:1900120 |
regulation of receptor binding(GO:1900120) |
| 0.0 |
0.6 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.7 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 |
0.2 |
GO:0032972 |
regulation of muscle filament sliding speed(GO:0032972) |
| 0.0 |
0.4 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 |
0.3 |
GO:0019541 |
acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.0 |
0.5 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.0 |
0.2 |
GO:0006210 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.0 |
0.1 |
GO:1901623 |
regulation of lymphocyte chemotaxis(GO:1901623) |
| 0.0 |
0.1 |
GO:0007509 |
mesoderm migration involved in gastrulation(GO:0007509) |
| 0.0 |
1.6 |
GO:0051350 |
negative regulation of lyase activity(GO:0051350) |
| 0.0 |
0.5 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.0 |
0.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.2 |
GO:0045747 |
positive regulation of Notch signaling pathway(GO:0045747) |
| 0.0 |
0.1 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.0 |
0.0 |
GO:2000328 |
regulation of T-helper 17 cell lineage commitment(GO:2000328) |
| 0.0 |
0.5 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.0 |
0.2 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.0 |
0.1 |
GO:0006972 |
hyperosmotic response(GO:0006972) cellular hyperosmotic response(GO:0071474) |
| 0.0 |
1.7 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.0 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.0 |
0.2 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.0 |
0.3 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.0 |
0.4 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.0 |
0.8 |
GO:0060122 |
inner ear receptor stereocilium organization(GO:0060122) |
| 0.0 |
0.4 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.0 |
0.5 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.4 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.6 |
GO:0098734 |
macromolecule depalmitoylation(GO:0098734) |
| 0.0 |
0.0 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.0 |
0.0 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.0 |
GO:1902186 |
regulation of viral release from host cell(GO:1902186) |
| 0.0 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.2 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.0 |
0.0 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.0 |
0.3 |
GO:0048743 |
positive regulation of skeletal muscle fiber development(GO:0048743) |
| 0.0 |
0.0 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) |
| 0.0 |
0.0 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.0 |
0.0 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.0 |
0.4 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
1.2 |
GO:1904030 |
negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.0 |
0.8 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.1 |
GO:0034154 |
toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.0 |
0.1 |
GO:0061014 |
positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 |
0.1 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.0 |
0.6 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 |
0.1 |
GO:0033138 |
positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.0 |
0.0 |
GO:0044650 |
adhesion of symbiont to host cell(GO:0044650) |
| 0.0 |
0.5 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.0 |
0.1 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.1 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.0 |
0.1 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.0 |
0.1 |
GO:0060605 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.0 |
0.1 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
1.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.2 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.0 |
0.1 |
GO:0051971 |
positive regulation of transmission of nerve impulse(GO:0051971) |
| 0.0 |
0.8 |
GO:0006032 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.0 |
0.3 |
GO:0043587 |
tongue morphogenesis(GO:0043587) |
| 0.0 |
0.3 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.4 |
GO:1902221 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.0 |
0.1 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.0 |
0.4 |
GO:0035115 |
embryonic forelimb morphogenesis(GO:0035115) |
| 0.0 |
0.3 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.0 |
0.0 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 |
0.2 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
0.1 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.0 |
0.2 |
GO:0002483 |
antigen processing and presentation of endogenous peptide antigen(GO:0002483) |
| 0.0 |
0.4 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.3 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.0 |
GO:1990403 |
embryonic brain development(GO:1990403) |
| 0.0 |
0.2 |
GO:0090650 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.0 |
0.1 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.0 |
1.2 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.0 |
0.2 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.2 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.0 |
0.2 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.1 |
GO:0072108 |
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
| 0.0 |
1.3 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 |
0.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.0 |
0.2 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.0 |
0.3 |
GO:0002249 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.0 |
0.2 |
GO:1904808 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.0 |
0.1 |
GO:1902714 |
negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.0 |
0.2 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.0 |
GO:0018202 |
peptidyl-histidine modification(GO:0018202) |
| 0.0 |
0.5 |
GO:0098712 |
L-glutamate import across plasma membrane(GO:0098712) |
| 0.0 |
0.2 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.0 |
0.1 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.0 |
0.3 |
GO:0051024 |
positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.0 |
0.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.1 |
GO:0002877 |
acute inflammatory response to non-antigenic stimulus(GO:0002525) regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
| 0.0 |
0.5 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 |
0.2 |
GO:0032688 |
negative regulation of interferon-beta production(GO:0032688) |
| 0.0 |
0.2 |
GO:0070234 |
positive regulation of T cell apoptotic process(GO:0070234) |
| 0.0 |
0.1 |
GO:0014744 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of muscle adaptation(GO:0014744) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.0 |
0.0 |
GO:0060352 |
cell adhesion molecule production(GO:0060352) |
| 0.0 |
0.1 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.2 |
GO:0061046 |
regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.0 |
0.2 |
GO:0051446 |
positive regulation of meiotic cell cycle(GO:0051446) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.2 |
GO:0045124 |
regulation of bone resorption(GO:0045124) |
| 0.0 |
1.8 |
GO:0070098 |
chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 |
0.2 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.0 |
0.2 |
GO:1903974 |
mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.0 |
0.5 |
GO:0036065 |
fucosylation(GO:0036065) |
| 0.0 |
0.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.0 |
3.8 |
GO:0006487 |
protein N-linked glycosylation(GO:0006487) |
| 0.0 |
0.3 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.9 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.3 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.0 |
0.2 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.0 |
0.2 |
GO:0042226 |
interleukin-6 biosynthetic process(GO:0042226) |
| 0.0 |
1.4 |
GO:0035036 |
sperm-egg recognition(GO:0035036) |
| 0.0 |
0.6 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
0.1 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.0 |
0.4 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
1.3 |
GO:0007040 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.1 |
GO:0002826 |
negative regulation of T-helper 1 type immune response(GO:0002826) |
| 0.0 |
0.1 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.0 |
0.4 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.0 |
0.1 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.0 |
0.4 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.0 |
0.1 |
GO:0061582 |
colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
| 0.0 |
0.0 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.0 |
0.0 |
GO:2001236 |
regulation of extrinsic apoptotic signaling pathway(GO:2001236) |
| 0.0 |
0.2 |
GO:0009397 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.0 |
0.5 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
2.8 |
GO:0030574 |
collagen catabolic process(GO:0030574) |
| 0.0 |
0.5 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0097067 |
response to thyroid hormone(GO:0097066) cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.0 |
0.1 |
GO:0035938 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.0 |
0.2 |
GO:0033363 |
secretory granule organization(GO:0033363) platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
1.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
1.3 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
0.1 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.0 |
0.3 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 0.0 |
0.2 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.5 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.1 |
GO:1904636 |
response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.0 |
0.2 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.0 |
0.1 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.0 |
0.2 |
GO:0036309 |
protein localization to M-band(GO:0036309) |
| 0.0 |
0.1 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.0 |
0.1 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.0 |
0.1 |
GO:0050807 |
regulation of synapse organization(GO:0050807) |
| 0.0 |
0.4 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.0 |
0.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.2 |
GO:0002052 |
positive regulation of neuroblast proliferation(GO:0002052) |
| 0.0 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.4 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.2 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.0 |
0.0 |
GO:0001562 |
response to protozoan(GO:0001562) |
| 0.0 |
0.2 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.8 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.1 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.0 |
0.1 |
GO:1904761 |
negative regulation of myofibroblast differentiation(GO:1904761) |
| 0.0 |
0.1 |
GO:0034205 |
beta-amyloid formation(GO:0034205) |
| 0.0 |
0.2 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.0 |
0.4 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.0 |
0.0 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.8 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.9 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.2 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.8 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.3 |
GO:0035278 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.0 |
0.3 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.2 |
GO:0043030 |
regulation of macrophage activation(GO:0043030) |
| 0.0 |
0.2 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.0 |
0.2 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.0 |
0.2 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.1 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.0 |
0.1 |
GO:0002727 |
natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
| 0.0 |
0.1 |
GO:0070839 |
spleen trabecula formation(GO:0060345) divalent metal ion export(GO:0070839) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.0 |
0.4 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.0 |
0.2 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.0 |
0.2 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.0 |
0.2 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.0 |
0.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.4 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.0 |
0.2 |
GO:0061439 |
renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.0 |
1.0 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
1.0 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.2 |
GO:0021615 |
glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 |
0.1 |
GO:0014858 |
positive regulation of skeletal muscle cell proliferation(GO:0014858) |
| 0.0 |
0.4 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.0 |
0.1 |
GO:0060425 |
lung morphogenesis(GO:0060425) |
| 0.0 |
0.1 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.0 |
0.1 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 |
0.0 |
GO:0051142 |
regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
| 0.0 |
0.1 |
GO:0045059 |
positive thymic T cell selection(GO:0045059) |
| 0.0 |
1.5 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0097194 |
execution phase of apoptosis(GO:0097194) |
| 0.0 |
0.3 |
GO:0051044 |
positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.0 |
0.1 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 |
0.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 |
0.4 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.0 |
0.1 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.0 |
0.4 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.0 |
0.0 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.0 |
0.1 |
GO:1904428 |
negative regulation of tubulin deacetylation(GO:1904428) |
| 0.0 |
0.3 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.6 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:0001836 |
release of cytochrome c from mitochondria(GO:0001836) |
| 0.0 |
0.2 |
GO:0033141 |
positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 |
0.1 |
GO:1902224 |
ketone body metabolic process(GO:1902224) |
| 0.0 |
0.1 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.0 |
1.2 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.2 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0060333 |
interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.0 |
0.3 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 0.0 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.0 |
0.0 |
GO:0071287 |
cellular response to manganese ion(GO:0071287) |
| 0.0 |
0.6 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.0 |
0.1 |
GO:0050829 |
defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 |
0.0 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0014009 |
glial cell proliferation(GO:0014009) |
| 0.0 |
0.0 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.0 |
0.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.1 |
GO:0072678 |
T cell migration(GO:0072678) |
| 0.0 |
1.3 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 |
0.0 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.0 |
0.1 |
GO:0006711 |
estrogen catabolic process(GO:0006711) |
| 0.0 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) regulation of toll-like receptor 9 signaling pathway(GO:0034163) negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
| 0.0 |
0.1 |
GO:0060389 |
pathway-restricted SMAD protein phosphorylation(GO:0060389) |
| 0.0 |
0.1 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 0.0 |
0.3 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) actin filament bundle organization(GO:0061572) |
| 0.0 |
0.1 |
GO:1900133 |
regulation of renin secretion into blood stream(GO:1900133) |
| 0.0 |
0.0 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
0.0 |
GO:0090024 |
negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
| 0.0 |
0.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.0 |
0.2 |
GO:0009826 |
unidimensional cell growth(GO:0009826) regulation of unidimensional cell growth(GO:0051510) negative regulation of unidimensional cell growth(GO:0051511) establishment of cell polarity regulating cell shape(GO:0071964) regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000769) positive regulation of establishment or maintenance of cell polarity regulating cell shape(GO:2000771) regulation of establishment of cell polarity regulating cell shape(GO:2000782) positive regulation of establishment of cell polarity regulating cell shape(GO:2000784) positive regulation of barbed-end actin filament capping(GO:2000814) |
| 0.0 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.1 |
GO:1904886 |
beta-catenin destruction complex disassembly(GO:1904886) |
| 0.0 |
0.1 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.0 |
0.2 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.0 |
GO:0050869 |
negative regulation of B cell activation(GO:0050869) |
| 0.0 |
0.4 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.1 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.0 |
0.0 |
GO:0071926 |
endocannabinoid signaling pathway(GO:0071926) |
| 0.0 |
0.2 |
GO:0086010 |
membrane depolarization during action potential(GO:0086010) |
| 0.0 |
0.2 |
GO:0019441 |
tryptophan catabolic process to kynurenine(GO:0019441) |
| 0.0 |
0.3 |
GO:0048704 |
embryonic skeletal system morphogenesis(GO:0048704) |
| 0.0 |
0.1 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.0 |
0.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.2 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.6 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.0 |
0.1 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.0 |
0.2 |
GO:0002523 |
leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 |
0.4 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.0 |
0.8 |
GO:0042438 |
melanin metabolic process(GO:0006582) melanin biosynthetic process(GO:0042438) |
| 0.0 |
0.2 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.2 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.0 |
0.3 |
GO:0007585 |
respiratory gaseous exchange(GO:0007585) |
| 0.0 |
0.0 |
GO:0030800 |
negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
| 0.0 |
0.2 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.0 |
0.1 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.0 |
0.1 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.0 |
0.0 |
GO:0042092 |
type 2 immune response(GO:0042092) |
| 0.0 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.0 |
0.1 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.0 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.0 |
0.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.0 |
0.2 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.0 |
0.2 |
GO:0048569 |
post-embryonic organ development(GO:0048569) |
| 0.0 |
0.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.4 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.0 |
0.0 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.0 |
0.1 |
GO:0007179 |
transforming growth factor beta receptor signaling pathway(GO:0007179) |
| 0.0 |
0.1 |
GO:0002430 |
complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.1 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.0 |
0.3 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
0.0 |
GO:0007608 |
sensory perception of smell(GO:0007608) |
| 0.0 |
0.1 |
GO:0051096 |
positive regulation of helicase activity(GO:0051096) |
| 0.0 |
0.0 |
GO:0038183 |
bile acid signaling pathway(GO:0038183) |
| 0.0 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.0 |
0.3 |
GO:0070571 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.0 |
0.2 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.0 |
0.7 |
GO:0015682 |
ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
| 0.0 |
0.1 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.0 |
0.1 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.0 |
0.8 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 |
0.2 |
GO:0009311 |
oligosaccharide metabolic process(GO:0009311) |
| 0.0 |
0.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 |
0.4 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.0 |
0.2 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.0 |
0.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.0 |
0.1 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.1 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.0 |
0.3 |
GO:0048730 |
epidermis morphogenesis(GO:0048730) |
| 0.0 |
0.0 |
GO:0002335 |
mature B cell differentiation(GO:0002335) |
| 0.0 |
0.1 |
GO:0071415 |
cellular response to purine-containing compound(GO:0071415) |
| 0.0 |
0.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.0 |
0.4 |
GO:0046676 |
negative regulation of insulin secretion(GO:0046676) |
| 0.0 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:1902630 |
regulation of membrane hyperpolarization(GO:1902630) |
| 0.0 |
0.1 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.0 |
0.2 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.1 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.0 |
0.4 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.1 |
GO:0048592 |
eye photoreceptor cell differentiation(GO:0001754) eye photoreceptor cell development(GO:0042462) eye morphogenesis(GO:0048592) |
| 0.0 |
0.1 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 |
0.0 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.0 |
0.1 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.0 |
0.2 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.0 |
GO:0060324 |
face development(GO:0060324) |
| 0.0 |
0.3 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.0 |
0.2 |
GO:0045843 |
negative regulation of striated muscle tissue development(GO:0045843) |
| 0.0 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.0 |
0.0 |
GO:0010002 |
cardioblast differentiation(GO:0010002) |
| 0.0 |
0.1 |
GO:0097284 |
hepatocyte apoptotic process(GO:0097284) |
| 0.0 |
0.3 |
GO:0021884 |
forebrain neuron development(GO:0021884) |
| 0.0 |
0.0 |
GO:1903778 |
protein localization to vacuolar membrane(GO:1903778) |
| 0.0 |
0.6 |
GO:0006739 |
NADP metabolic process(GO:0006739) |
| 0.0 |
0.0 |
GO:0002437 |
inflammatory response to antigenic stimulus(GO:0002437) |
| 0.0 |
0.0 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.0 |
0.1 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.0 |
0.1 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.0 |
0.3 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.0 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 0.0 |
0.4 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.1 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.0 |
0.0 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 0.0 |
0.1 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.0 |
0.1 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.0 |
0.0 |
GO:0002372 |
myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 |
0.1 |
GO:0044789 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.0 |
0.0 |
GO:1901876 |
regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.0 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.0 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.0 |
0.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.0 |
0.4 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.2 |
GO:2000059 |
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.0 |
0.2 |
GO:0000423 |
macromitophagy(GO:0000423) |
| 0.0 |
0.1 |
GO:0001763 |
morphogenesis of a branching structure(GO:0001763) |
| 0.0 |
0.0 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.3 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.0 |
0.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.0 |
0.0 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.0 |
GO:1904018 |
positive regulation of vasculature development(GO:1904018) |
| 0.0 |
0.0 |
GO:0045338 |
farnesyl diphosphate metabolic process(GO:0045338) |
| 0.0 |
0.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 |
0.2 |
GO:0051149 |
positive regulation of muscle cell differentiation(GO:0051149) |
| 0.0 |
0.1 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.0 |
0.2 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.0 |
0.2 |
GO:0071688 |
striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.0 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.0 |
0.1 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.0 |
0.0 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.3 |
GO:1901385 |
regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.0 |
0.1 |
GO:0071352 |
cellular response to interleukin-2(GO:0071352) |
| 0.0 |
0.0 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.0 |
0.0 |
GO:0030826 |
regulation of cGMP metabolic process(GO:0030823) positive regulation of cGMP metabolic process(GO:0030825) regulation of cGMP biosynthetic process(GO:0030826) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.0 |
0.0 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.0 |
0.0 |
GO:1903012 |
positive regulation of bone development(GO:1903012) |
| 0.0 |
0.1 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.0 |
0.0 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.0 |
0.0 |
GO:0006006 |
glucose metabolic process(GO:0006006) |
| 0.0 |
0.2 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.0 |
0.0 |
GO:1901374 |
acetate ester transport(GO:1901374) |
| 0.0 |
0.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.2 |
GO:0010831 |
positive regulation of myotube differentiation(GO:0010831) |
| 0.0 |
0.1 |
GO:0061037 |
negative regulation of chondrocyte differentiation(GO:0032331) negative regulation of cartilage development(GO:0061037) |
| 0.0 |
0.2 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.0 |
0.1 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.0 |
0.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.0 |
0.0 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) |
| 0.0 |
0.0 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
